BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 17440684)

  • 21. Biological consequences of tumor hypoxia.
    Höckel M; Vaupel P
    Semin Oncol; 2001 Apr; 28(2 Suppl 8):36-41. PubMed ID: 11395851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of supervised gene signatures of early hypoxia on patient survival.
    Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P
    Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
    Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxygenation of human tumors: the Mainz experience.
    Vaupel P; Thews O; Kelleher DK; Hoeckel M
    Strahlenther Onkol; 1998 Dec; 174 Suppl 4():6-12. PubMed ID: 9879340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response.
    Vaupel P; Harrison L
    Oncologist; 2004; 9 Suppl 5():4-9. PubMed ID: 15591417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
    Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells.
    Alqawi O; Wang HP; Espiritu M; Singh G
    Free Radic Res; 2007 Jul; 41(7):788-97. PubMed ID: 17577739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.
    Hoogsteen IJ; Marres HA; van der Kogel AJ; Kaanders JH
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):385-96. PubMed ID: 17433637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of HIF-1-active cells in angiogenesis and radioresistance.
    Harada H; Kizaka-Kondoh S; Li G; Itasaka S; Shibuya K; Inoue M; Hiraoka M
    Oncogene; 2007 Nov; 26(54):7508-16. PubMed ID: 17563752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.
    Kolev Y; Uetake H; Takagi Y; Sugihara K
    Ann Surg Oncol; 2008 Aug; 15(8):2336-44. PubMed ID: 18521687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.